title: Epistaxis in a patient on antiplatelet therapy: not always benign.
abstract: Epistaxis in patients on antiplatelet and anticoagulant therapy is common and typically benign. We present a case of a rare nasal septal malignancy in a patient on antiplatelet therapy and discuss worrisome symptoms and signs which should prompt early referral to a specialist.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN.
authors.forename: Mark
authors.initials: M
authors.lastname: Strand
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN. Electronic address: meye1732@umn.edu.
authors.forename: Jason
authors.initials: J
authors.lastname: Meyers
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, MN.
authors.forename: Holly
authors.initials: H
authors.lastname: Boyer
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000150:complications* / Q000473:pathology; D004844:Epistaxis / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D008297:Male; D009300:Nasal Septum; D009669:Nose Neoplasms / Q000150:complications* / Q000473:pathology; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D012008:Recurrence
chemical_list: D010975:Platelet Aggregation Inhibitors